0001213900-16-014439.txt : 20160622 0001213900-16-014439.hdr.sgml : 20160622 20160622173725 ACCESSION NUMBER: 0001213900-16-014439 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160616 FILED AS OF DATE: 20160622 DATE AS OF CHANGE: 20160622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krumeich Karen R CENTRAL INDEX KEY: 0001334797 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 161727260 MAIL ADDRESS: STREET 1: 3 WEST MAIN STREET STREET 2: SUITE 201 CITY: IRVINGTON STATE: NY ZIP: 10533 4 1 f4061616krumeich_soligenix.xml OWNERSHIP DOCUMENT X0306 4 2016-06-16 0 0000812796 SOLIGENIX, INC. SNGX 0001334797 Krumeich Karen R 29 EMMONS DRIVE, SUITE C-10 PRINCETON NJ 08540 0 1 0 0 SVP and CFO Option (Right to Buy) 0.74 2016-06-16 4 A 0 100000 0 A 2016-06-16 2026-06-15 Common Stock 100000 100000 D The stock option vested immediately as to 25,000 shares and vests as to the remainder at a rate of 6,250 of the shares on each three (3) month anniversary of June 16, 2016. /s/ Karen R. Krumeich 2016-06-22